Suppr超能文献

[腹泻病补液疗法的发展。1980年]

[Development of a rehydration therapy in diarrheic disease. 1980].

作者信息

Benenson A S

机构信息

Laboratorio Conmemorativo Gorgas.

出版信息

Rev Med Panama. 1991 Sep;16(3):161-72.

PMID:1767034
Abstract

Intravenous rehydration is required only in patients with severe diarrhea due to V. cholerae who are in shock, with absent peripheral pulse and blood pressure; when the shock has been corrected, rehydration can be completed using an oral rehydration solution. The intravenous solution to be used is 5:4: 1 (5g of sodium chloride, 4g of sodium bicarbonate and 1g of potassium chloride per liter) or a comparable commercial alkaline solution. For oral rehydration a solution is used containing 3.5 g sodium chloride, 2.5g sodium bicarbonate, 1.5g potassium chloride and 20g of glucose (or 40g of sucrose) per liter. These fluids are administered in a volume replacing the amount lost before treatment was initiated and the fluids lost in the continuing diarrhea. With this management, a case fatality rate of 50% in the untreated falls to less than 1%. The addition of antibiotics such as tetracycline and furazolidone reduces the duration of diarrhea and the need for continuing fluid balance observation. Intravenous rehydration of severe diarrhea cases with normal saline solution or with 5% glucose solution increases the acidosis with resulting veno-constriction, which favors the pooling of blood in the heart and the pulmonary circulation leading to cardiac overload and then failure and circulatory peripheral collapse. When acidosis is corrected by the sodium bicarbonate solution and with adequate fluid replacement, normal hemodynamics are reestablished and the patient immediately recovers from the collapse. In cases of mild or moderate diarrhea, replacement entirely by oral rehydration of the estimated volume of lost fluid alone is usually sufficient. This management of diarrhea is applicable for diarrhea from any cause, including enterotoxigenic Escherichia coli, Rotavirus, Salmonella and Shigella as well as Vibrio cholerae.

摘要

仅因霍乱弧菌导致严重腹泻且处于休克状态、外周脉搏和血压消失的患者才需要静脉补液;休克纠正后,可使用口服补液溶液完成补液。使用的静脉补液溶液为5:4:1(每升含5克氯化钠、4克碳酸氢钠和1克氯化钾)或类似的市售碱性溶液。口服补液时,使用的溶液每升含3.5克氯化钠、2.5克碳酸氢钠、1.5克氯化钾和20克葡萄糖(或40克蔗糖)。这些液体的输注量应补充治疗开始前丢失的量以及持续腹泻中丢失的液体量。采用这种治疗方法,未经治疗的病死率为50%,而现在可降至1%以下。添加四环素和呋喃唑酮等抗生素可缩短腹泻持续时间,并减少持续进行液体平衡观察的必要性。用生理盐水溶液或5%葡萄糖溶液对严重腹泻病例进行静脉补液会加重酸中毒,导致静脉收缩,这有利于血液在心脏和肺循环中淤积,进而导致心脏超负荷,然后是心力衰竭和循环外周衰竭。当用碳酸氢钠溶液纠正酸中毒并进行充分的液体替代时,可重建正常的血液动力学,患者会立即从衰竭中恢复。对于轻度或中度腹泻病例,仅通过口服补液完全补充估计的失液量通常就足够了。这种腹泻治疗方法适用于任何原因引起的腹泻,包括产肠毒素大肠杆菌、轮状病毒、沙门氏菌、志贺氏菌以及霍乱弧菌引起的腹泻。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验